Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

被引:322
作者
Caruso, Hillary G. [1 ,2 ]
Hurton, Lenka V. [1 ,2 ]
Najjar, Amer [1 ]
Rushworth, David [1 ,2 ]
Ang, Sonny [1 ]
Olivares, Simon [1 ]
Mi, Tiejuan [1 ]
Switzer, Kirsten [1 ]
Singh, Harjeet [1 ]
Huls, Helen [1 ]
Lee, Dean A. [1 ,2 ]
Heimberger, Amy B. [3 ]
Champlin, Richard E. [4 ]
Cooper, Laurence J. N. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA
[2] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular, Houston, TX 77030 USA
关键词
EPIDERMAL-GROWTH-FACTOR; RECEPTOR T-CELLS; ANTIGEN-PRESENTING CELLS; AFFINITY; BINDING; ANTIBODY; NIMOTUZUMAB; ACTIVATION; STRENGTH; LIGANDS;
D O I
10.1158/0008-5472.CAN-15-0139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many tumors overexpress tumor-associated antigens relative to normal tissue, such as EGFR. This limits targeting by human T cells modified to express chimeric antigen receptors (CAR) due to potential for deleterious recognition of normal cells. We sought to generate CAR(+) T cells capable of distinguishing malignant from normal cells based on the disparate density of EGFR expression by generating two CARs from monoclonal antibodies that differ in affinity. T cells with low-affinity nimotuzumab-CAR selectively targeted cells overexpressing EGFR, but exhibited diminished effector function as the density of EGFR decreased. In contrast, the activation of T cells bearing high-affinity cetuximab-CAR was not affected by the density of EGFR. In summary, we describe the generation of CARs able to tune T-cell activity to the level of EGFR expression in which a CAR with reduced affinity enabled T cells to distinguish malignant from nonmalignant cells. (C)2015 AACR.
引用
收藏
页码:3505 / 3518
页数:14
相关论文
共 50 条
[1]   Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia [J].
Barrett, David M. ;
Liu, Xiaojun ;
Jiang, Shuguang ;
June, Carl H. ;
Grupp, Stephan A. ;
Zhao, Yangbing .
HUMAN GENE THERAPY, 2013, 24 (08) :717-727
[2]   Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies [J].
Beatty, Gregory L. ;
Haas, Andrew R. ;
Maus, Marcela V. ;
Torigian, Drew A. ;
Soulen, Michael C. ;
Plesa, Gabriela ;
Chew, Anne ;
Zhao, Yangbing ;
Levine, Bruce L. ;
Albelda, Steven M. ;
Kalos, Michael ;
June, Carl H. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :112-120
[3]  
BIGNER SH, 1990, CANCER RES, V50, P8017
[4]   Requirements for peptide-induced T cell receptor downregulation on naive CD8(+) T cells [J].
Cai, ZL ;
Kishimoto, H ;
Brunmark, A ;
Jackson, MR ;
Peterson, PA ;
Sprent, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :641-651
[5]   Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses [J].
Chervin, A. S. ;
Stone, J. D. ;
Soto, C. M. ;
Engels, B. ;
Schreiber, H. ;
Roy, E. J. ;
Kranz, D. M. .
GENE THERAPY, 2013, 20 (06) :634-644
[6]   T cell activation by antibody-like immunoreceptors: Increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity [J].
Chmielewski, M ;
Hombach, A ;
Heuser, C ;
Adams, GP ;
Abken, H .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7647-7653
[7]   Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses [J].
Corse, Emily ;
Gottschalk, Rachel A. ;
Allison, James P. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (09) :5039-5045
[8]   Attenuated T Cell Responses to a High-Potency Ligand In Vivo [J].
Corse, Emily ;
Gottschalk, Rachel A. ;
Krogsgaard, Michelle ;
Allison, James P. .
PLOS BIOLOGY, 2010, 8 (09)
[9]   Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy [J].
Di Stasi, Antonio ;
Tey, Siok-Keen ;
Dotti, Gianpietro ;
Fujita, Yuriko ;
Kennedy-Nasser, Alana ;
Martinez, Caridad ;
Straathof, Karin ;
Liu, Enli ;
Durett, April G. ;
Grilley, Bambi ;
Liu, Hao ;
Cruz, Conrad R. ;
Savoldo, Barbara ;
Gee, Adrian P. ;
Schindler, John ;
Krance, Robert A. ;
Heslop, Helen E. ;
Spencer, David M. ;
Rooney, Cliona M. ;
Brenner, Malcolm K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1673-1683
[10]   PD-1-and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses [J].
Fedorov, Victor D. ;
Themeli, Maria ;
Sadelain, Michel .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (215)